Skip to main content

Advertisement

SpringerLink
Log in

Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke

  • Clinical Research Report
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  • Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24(1):35–41

    Article  Google Scholar 

  • Amarenco P, Lavallée PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H et al (2018) Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med 378(23):2182–2190

    Article  Google Scholar 

  • Assis DN, Leng L, Du X et al (2014) The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology 59(2):580–591

    Article  CAS  Google Scholar 

  • Bai B, Yan Z, Hao Y, Zhang Z, Li G, Dekker J, Qiu C (2017) A randomised controlled multimodal intervention trial in patients with ischaemic stroke in Shandong, China: design and rationale. Lancet 390:S13

    Article  Google Scholar 

  • Bamford J, Sandercock P, Dennis M, Warlow C, Burn J (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337(8756):1521–1526

    Article  CAS  Google Scholar 

  • Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3(3):170–176

    Article  CAS  Google Scholar 

  • Boekholdt SM, Peters RJ, Day NE, Luben R, Bingham SA, Wareham NJ, Khaw KT (2004) Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk prospective population study. Am J Med 117(6):390–397

    Article  Google Scholar 

  • Bozza FA, Gomes RN, Japiassú AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22(4):309–313

    Article  CAS  Google Scholar 

  • Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870

    Article  CAS  Google Scholar 

  • Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, Dimmeler S, Kleemann R, Bernhagen J, Ihling C (2002) Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105(13):1561–1566

    Article  CAS  Google Scholar 

  • Cabral NL, Nagel V, Conforto AB, Amaral CH, Venancio VG, Safanelli J et al (2018) Five-year survival, disability, and recurrence after first-ever stroke in a middle-income country: a population-based study in Joinvile, Brazil. Int J Stroke 1747493018763906

  • Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800

    Article  CAS  Google Scholar 

  • Chatterjee M, Borst O, Walker B, Fotinos A, Vogel S, Seizer P et al (2014) Macrophage migration inhibitory factor (MIF) limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. Circ Res 115:939–949

    Article  CAS  Google Scholar 

  • Chen HR, Chuang YC, Chao CH, Yeh TM (2015a) Macrophage migration inhibitory factor induces vascular leakage via autophagy. Biology open 4(2):244–252

    Article  CAS  Google Scholar 

  • Chen L, Zhou X, Fan LX, Yao Y, Swenson-Fields KI, Gadjeva M, Wallace DP, Peters DJM, Yu A, Grantham JJ, Li X (2015b) Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J Clin Invest 125(6):2399–2412

    Article  Google Scholar 

  • Chuang TY, Chang HT, Chung KP, Cheng HS, Liu CY, Liu YC et al (2014) High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis. Int J Infect Dis 20:13–17

    Article  CAS  Google Scholar 

  • Conroy H, Mawhinney L, Donnelly SC (2010) Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link. QJM: An International Journal of Medicine 103(11):831–836

    Article  CAS  Google Scholar 

  • Donnelly SC, Bucala R (1997) Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Molecular medicine today 3(11):502–507

    Article  CAS  Google Scholar 

  • Fernández-Cadenas, I., Mendióroz, M., Giralt, D., Nafria, C., Garcia, E., Carrera, C., ... & Castellanos, M. (2017). GRECOS project (genotyping recurrence risk of stroke) the use of genetics to predict the vascular recurrence after stroke. Stroke, 48(5), 1147–1153

  • Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54(5):541–553

    CAS  PubMed  PubMed Central  Google Scholar 

  • Herder C, Illig T, Baumert J, Müller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W (2008) Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Atherosclerosis 200(2):380–388

    Article  CAS  Google Scholar 

  • Huang H, Zheng T, Wang S, Wei L, Wang Q, Sun Z (2016) Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients. Nutr Metab Cardiovasc Dis 26(10):908–914

    Article  CAS  Google Scholar 

  • Inácio AR, Ruscher K, Leng L, Bucala R, Deierborg T (2011) Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab 31(4):1093–1106

    Article  Google Scholar 

  • Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R et al (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66(6):799–808

    Article  CAS  Google Scholar 

  • Koda M, Nishio Y, Hashimoto M, Kamada T, Koshizuka S, Yoshinaga K, Onodera S, Nishihira J, Moriya H, Yamazaki M (2004) Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol 108(1):31–36

    Article  CAS  Google Scholar 

  • Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, Ojamaa K (2011) Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 14(7):1191–1202

    Article  CAS  Google Scholar 

  • Le Hiress M, Tu L, Ricard N, Phan C, Thuillet R, Fadel E et al (2015) Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complex. Am J Respir Crit Care Med 192(8):983–997

    Article  Google Scholar 

  • Lehmann L, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A, Stüber F (2001) Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27(8):1412–1415

    Article  CAS  Google Scholar 

  • Levine DA, Kiefe CI, Houston TK, Allison JJ, McCarthy EP, Ayanian JZ (2007) Younger stroke survivors have reduced access to physician care and medications: National Health Interview Survey from years 1998 to 2002. Arch Neurol 64(1):37–42

    Article  Google Scholar 

  • Leyton-Jaimes MF, Kahn J, Israelson A (2018) Macrophage migration inhibitory factor: a multifaceted cytokine implicated in multiple neurological diseases. Exp Neurol 301:83–91

    Article  CAS  Google Scholar 

  • Li YS, Chen W, Liu S, Zhang YY, Li XH (2017) Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke. Int J Neurosci 127(6):539–546

    Article  CAS  Google Scholar 

  • Lin Q, Cai JY, Lu C, Sun J, Ba HJ, Chen MH, Chen XD, Dai JX, Lin JH (2017) Macrophage migration inhibitory factor levels in serum from patients with acute intracerebral hemorrhage: potential contribution to prognosis. Clin Chim Acta 472:58–63

    Article  CAS  Google Scholar 

  • Liu YC, Tsai YH, Tang SC, Liou HC, Kang KH, Liou HH, Jeng JS, Fu WM (2018) Cytokine MIF enhances blood-brain barrier permeability: impact for therapy in ischemic stroke. Sci Rep 8(1):743

    Article  Google Scholar 

  • Luedike P, Alatzides G, Papathanasiou M, Heisler M, Pohl J, Lehmann N, Rassaf T (2018a) Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF). Eur J Med Res 23(1):22

    Article  Google Scholar 

  • Luedike P, Alatzides G, Papathanasiou M, Heisler M, Pohl J, Lehmann N, Rassaf T (2018b) Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure. Cytokine 110:104–109

    Article  CAS  Google Scholar 

  • Lv W, Chen N, Lin Y, Ma H, Ruan Y, Li Z, Li X, Pan X, Tian X (2016) Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. Cancer Lett 375(2):245–255

    Article  CAS  Google Scholar 

  • Makino A, Nakamura T, Hirano M, Kitta Y, Sano K, Kobayashi T et al (2010) High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. Atherosclerosis 213(2):573–578

    Article  CAS  Google Scholar 

  • Morrison MC, Kleemann R (2015) Role of macrophage migration inhibitory factor in obesity, insulin resistance, type 2 diabetes, and associated hepatic co-morbidities: a comprehensive review of human and rodent studies. Front Immunol 6:308

    Article  Google Scholar 

  • Müller II, Müller KA, Schönleber H, Karathanos A, Schneider M, Jorbenadze R et al (2012) Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS One 7(6):e38376

    Article  Google Scholar 

  • Okazaki S, Hishimoto A, Otsuka I, Watanabe Y, Numata S, Boku S et al (2018) Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 83:33–41

    Article  CAS  Google Scholar 

  • Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157–172

    Article  Google Scholar 

  • Sacco RL, Wolf PA, Gorelick PB (1999) Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology 53(7 Suppl 4):S15–S24

    CAS  PubMed  Google Scholar 

  • Sanchez-Zamora Y, Terrazas LI, Vilches-Flores A, Leal E, Juárez I, Whitacre C, Kithcart A, Pruitt J, Sielecki T, Satoskar AR, Rodriguez-Sosa M (2010) Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J 24(7):2583–2590

    Article  CAS  Google Scholar 

  • Sánchez-Zamora YI, Rodriguez-Sosa M (2014) The role of MIF in type 1 and type 2 diabetes mellitus. J. Diabetes Res. 2014:1–6

    Article  Google Scholar 

  • Sobierajski J, Hendgen-Cotta UB, Luedike P, Stock P, Rammos C, Meyer C, Kraemer S, Stoppe C, Bernhagen J, Kelm M, Rassaf T (2013) Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels. Free Radic Biol Med 63:236–242

    Article  CAS  Google Scholar 

  • Sposato LA, Cerasuolo JO, Cipriano LE, Fang J, Fridman S, Paquet M et al (2018) Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence. Neurology 90(11):e924–e931

    Article  Google Scholar 

  • Stoppe C, Averdunk L, Goetzenich A, Soppert J, Marlier A, Kraemer S et al (2018) The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med 10(441):eaan4886

    Article  Google Scholar 

  • Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B et al (2018) MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med 379:611–622. https://doi.org/10.1056/NEJMoa1804355

    Article  PubMed  Google Scholar 

  • Tu WJ, Zhao SJ, Xu DJ, Chen H (2014) Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin Sci 126(5):339–346

    Article  CAS  Google Scholar 

  • Tu WJ, Zeng XW, Deng A, Zhao SJ, Luo DZ, Ma GZ, Wang H, Liu Q (2017) Circulating FABP4 (fatty acid–binding protein 4) is a novel prognostic biomarker in patients with acute ischemic stroke. Stroke 48(6):1531–1538

    Article  CAS  Google Scholar 

  • Turtzo LC, Li J, Persky R, Benashski S, Weston G, Bucala R, Venna VR, McCullough LD (2013) Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice. Neurobiol Dis 54:421–431

    Article  CAS  Google Scholar 

  • Xu T, Pu S, Ni Y, Gao M, Li X, Zeng X (2018) Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke. J Neuroimmunol 320:58–63

    Article  CAS  Google Scholar 

  • Wang L, Zis O, Ma G, Shan Z, Zhang X, Wang S, Dai C, Zhao J, Lin Q, Lin S, Song W (2009) Upregulation of macrophage migration inhibitory factor gene expression in stroke. Stroke 40(3):973–976

    Article  CAS  Google Scholar 

  • Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, Wang A, Meng X, Li H, Wang Y (2013) Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 44(5):1232–1237

    Article  CAS  Google Scholar 

  • Yang DB, Yu WH, Dong XQ, Zhang ZY, Du Q, Zhu Q et al (2017) Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury. Clin Chim Acta 469:99–104

    Article  CAS  Google Scholar 

  • Yüksel A, Bilgir F, Bilgir O, Calan M, Bozkaya G (2015) Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease. Clinics 70(3):169–172

    Article  Google Scholar 

  • Zernecke A, Bernhagen J, Weber C (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117(12):1594–1602

    Article  CAS  Google Scholar 

  • Zhang Q, Ding H, Yan J, Wang W, Ma A, Zhu Z, Cianflone K, Hu FB, Hui R, Wang DW (2011) Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case–control study in China. Ann Neurol 70(2):265–273

    Article  CAS  Google Scholar 

  • Zis O, Zhang S, Dorovini-Zis K, Wang L, Song W (2015) Hypoxia signaling regulates macrophage migration inhibitory factor (MIF) expression in stroke. Mol Neurobiol 51(1):155–167

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We also express our gratitude to all the patients who participated in this study, and thereby made this work possible. All authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. The content has not been published or submitted for publication elsewhere.

Role of the Sponsor

The funding organizations had no role in the design and concept of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.

Funding

This study was supported by grants from National Natural Science Foundation of China (No. 81671079).

Author information

Authors and Affiliations

  1. Department of Neurology II, Zhoukou Central Hospital, No. 26 Renmin Road East, Zhoukou, 466000, Henan Province, People’s Republic of China

    Guangjie Wang, Chuanbin Li, Yashou Liu & Lei Xia

Authors
  1. Guangjie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chuanbin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yashou Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lei Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lei Xia.

Ethics declarations

Conflict of Interest

The authors have no relevant potential conflicts of interest to declare.

Ethics Approval

The study was approved by the ethics committee of Zhoukou Central Hospital. The patients or their relatives gave written informed consent prior to entering the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 937 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, G., Li, C., Liu, Y. et al. Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke. Neurotox Res 36, 1–11 (2019). https://doi.org/10.1007/s12640-018-9984-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-018-9984-1

Search

Navigation